Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
679.00    -6.00 (-0.88%)
Bid:
678.00
Ask:
680.00
Spread: 2.00 (0.295%)
Market Cap: £659.45m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Trading Update

19 Apr 2011 07:00

RNS Number : 1357F
Acal PLC
19 April 2011
 



For Release

7.00am, 19 April 2011

 

 

Acal plc

Fourth Quarter Trading Update

Continuing strong growth with Group like for like sales1 up 17%

 

Acal plc (LSE : ACL, "The Group"), the European specialist provider of technology products and services, is today issuing a trading update for its year ended 31 March 2011, ahead of the announcement of its preliminary results on 1 June 2011.

 

The Board is pleased to report that, since its second interim management statement on 3 February 2011, trading has continued to remain strong. In the fourth quarter ended 31 March 2011, Group like for like sales1 increased by 17% year on year.

 

Group sales continue to be driven by a strong Electronics order book. The Electronics division (which accounts for approximately 78% of Group sales) reported a fourth quarter increase in like for like sales1 of 21% despite more challenging comparators.

 

Sales of products manufactured in Japan (all of which are in the Electronics division and represent approximately 4% of Group revenues), were not significantly impacted by the earthquake in mid March and Acal has continued to meet its customers' needs. 

 

The acquisition of Compotron GmbH ("Compotron"), a specialist provider of electronic communication components, was completed with effect from 1 January 2011. Since the acquisition, Compotron has performed well and ahead of our expectations.

 

In the non-Electronics businesses (approximately 22% of Group sales), total like for like sales1 in the fourth quarter were up 7%.

 

As a result, we expect full year results for this year to be ahead of our previous expectations.

 

Nick Jefferies, Group Chief Executive commented:

 

"We continue to see good trading conditions in the Electronics Division across Europe. With its strong order book, Electronics like for like sales1 increased by 21% in the last quarter.

 

Overall, Group sales increased by 17%, with the non-Electronics businesses showing improved performance despite continued softness in our UK Medical business.

 

The Board remains confident that our strategy for growth both organically and by further targeted acquisitions will continue to build long term value for shareholders."

For further information please contact:

Acal plc

Nick Jefferies - Group Chief Executive

Simon Gibbins - Group Finance Director

 

Cubitt Consulting

Chris Lane / Alice Coubrough

01483 544500

 

 

 

020 7367 5100

 

 

 

Notes to the Trading Update

1. Like for like sales are at constant exchange rates, including acquisitions for the whole of the comparative period and excluding the ATM Parts business (effective disposal date 30 September 2010) and a material non-core Supply Chain contract terminated at the end of the last financial year. Compotron, which was acquired in the fourth quarter, has not been included in like for like sales.

 

 Notes to Editors:

 

About Acal plc

The Acal Group is a leading technology-based specialist distributor in Europe providing sales, marketing and other services through three divisions: Electronics, Supply Chain and Medical. The Electronics Division distributes electronic and photonic products to industrial manufacturing and design companies. The Supply Chain Division provides inventory optimisation and outsource solutions to leading technology service providers while the Medical Division supplies advanced medical equipment to public and private healthcare providers. Acal has operating companies in the UK, Netherlands, Belgium, Germany, France, Italy, South Africa, Spain and the Nordic region.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKFDQABKDOQD
Date   Source Headline
16th Jan 202010:57 amRNSHolding(s) in Company
23rd Dec 20199:26 amRNSHolding(s) in Company
9th Dec 20198:42 amRNSHolding(s) in Company
28th Nov 20197:00 amRNSHalf-year Report
19th Nov 20192:58 pmRNSDirector Declaration
23rd Oct 201910:44 amRNSHolding(s) in Company
23rd Oct 20199:01 amRNSHolding(s) in Company
17th Oct 20191:15 pmRNSResults of Placing
17th Oct 20197:00 amRNSAcquisition & Proposed Placing
10th Oct 20197:00 amRNSTrading Update
2nd Sep 20197:00 amRNSDirector Declaration
25th Jul 20191:38 pmRNSResult of AGM
25th Jul 20197:00 amRNSTrading Update
24th Jul 20199:00 amRNSIssue of Equity
10th Jul 201911:40 amRNSHolding(s) in Company
25th Jun 201911:31 amRNSAnnual Report and Accounts
4th Jun 20197:00 amRNSFinal Results
3rd May 20192:48 pmRNSHolding(s) in Company
1st May 20194:21 pmRNSDirector LTIP Award
30th Apr 20199:00 amRNSDirectorate Change
24th Apr 201911:21 amRNSHolding(s) in Company
18th Apr 201911:57 amRNSDirector/PDMR Shareholding
16th Apr 20191:08 pmRNSDirector Declaration
16th Apr 201911:35 amRNSResults of Placing
16th Apr 20197:01 amRNSAcquisitions & Proposed Placing
16th Apr 20197:00 amRNSTrading Update
18th Mar 20192:52 pmRNSHolding(s) in Company
15th Mar 20197:00 amRNSBoard and Committee Changes
8th Feb 20199:22 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
5th Dec 201810:12 amRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSHalf-year Report
17th Oct 20187:00 amRNSAcquisition
11th Oct 20187:00 amRNSTrading Update
10th Sep 20183:17 pmRNSIssue of Equity
22nd Aug 201811:30 amRNSHolding(s) in Company
26th Jul 20182:45 pmRNSResult of General Meeting
26th Jul 20182:40 pmRNSResult of AGM
26th Jul 20187:00 amRNSTrading Update
11th Jul 20182:17 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPublication of Circular and Notice of EGM
26th Jun 20184:46 pmRNSAnnual Report and Accounts
19th Jun 20183:03 pmRNSIssue of Equity
11th Jun 201810:56 amRNSHolding(s) in Company
7th Jun 20184:08 pmRNSDirector/PDMR Shareholding
6th Jun 20189:00 amRNSExercise of share options
5th Jun 20187:00 amRNSFinal Results
19th Apr 20187:00 amRNSTrading Update
29th Mar 20182:15 pmRNSDirector/PDMR Shareholding
27th Mar 20182:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.